| Literature DB >> 31754300 |
Michal Elboim-Gabyzon1, Sahar Andrawus Najjar2,3, Haim Shtarker3,4.
Abstract
BACKGROUND: Transcutaneous electrical nerve stimulation (TENS) is a noninvasive modality which may be used to reduce acute postoperative pain. Intense perioperative pain within the first few days after hip fracture surgery is common and is related to negative consequences such as restricted and delayed ambulation.Entities:
Keywords: TENS; acute postoperative; hip fracture; mobility; pain; transcutaneous electrical nerve stimulation
Mesh:
Year: 2019 PMID: 31754300 PMCID: PMC6825510 DOI: 10.2147/CIA.S203658
Source DB: PubMed Journal: Clin Interv Aging ISSN: 1176-9092 Impact factor: 4.458
Figure 1Flowchart of the study.
Baseline Characteristics Of Each Group (Mean ± SD), And Comparison Between Groups (p-Value)
| Characteristics | Sham TENS (n=18) | Active TENS (n=23) | p value |
|---|---|---|---|
| Age, mean ± SD | 78.06±8.45 | 80.26±9.83 | 0.45 |
| Gender, n | 0.12 | ||
| Men | 6 | 3 | |
| Women | 12 | 20 | |
| Operated side, n | 0.09 | ||
| Left | 11 | 8 | |
| Right | 7 | 15 | |
| Comorbidities, n | 0.13 | ||
| 0–2 pathology | 7 | 11 | |
| 3–5 pathology | 11 | 12 | |
| Assistive device pre-fracture, n | 0.17 | ||
| None | 3 | 2 | |
| Cane | 1 | 9 | |
| Walker | 14 | 12 |
Note: Statistical significance p < 0.05.
Pain Intensity Over Time Of The Study Groups (Mean ± SD) (Wilcoxon Signed Rank Test; P Value) And Between Groups (Wilcoxon Scores; Rank Sum; P-Value)
| Outcome measures | Sham TENS (n=18) | p value | Active TENS (n=23) | p value | Between group |
|---|---|---|---|---|---|
| Day 1 | 6.12±2.50* | – | 4.17±1.92 | – | 0.02 |
| Day 2 | 5.47±2.43* | – | 3.91±2.02 | – | 0.07 |
| Day 3 | 4.65±2.42* | – | 3.39±1.99 | – | 0.09 |
| Day 4 | 4.47±2.24* | – | 2.83±1.75 | – | 0.02 |
| Day 5 | 4.47±2.48* | – | 2.83±1.97 | – | 0.03 |
| Day 1–Day 5 | 1.65±1.80* | 0.004 | 1.35±1.77 | 0.002 | 0.64 |
| Day 2–Day 5 | 1.00±1.66* | 0.02 | 1.09±1.53 | 0.004 | 0.91 |
| Day 1 | 7.56±1.89 | – | 6.13±3.05 | – | 0.13 |
| Day 2 | 7.39±1.97 | – | 6.04±2.65 | – | 0.08 |
| Day 3 | 6.56±2.53 | – | 5.00±2.71 | – | 0.06 |
| Day 4 | 6.17±2.73 | – | 4.57±2.59 | – | 0.02 |
| Day 5 | 5.94±2.82 | – | 4.17±2.72 | – | 0.03 |
| Day 1–Day 5 | 1.61±2.85 | 0.02 | 1.96±2.70 | 0.002 | 0.60 |
| Day 2–Day 5 | 1.44±2.73 | 0.02 | 1.87±2.01 | <0.0001 | 0.43 |
| Day 2 | 8.17±1.29 | – | 7.50±1.41** | – | 0.13 |
| Day 3 | 7.83±1.34 | – | 6.18±1.47** | – | 0.002 |
| Day 4 | 7.28±1.23 | – | 5.61±1.64 | – | 0.002 |
| Day 5 | 7.11±1.45 | – | 4.96±1.58 | – | 0.0002 |
| Day 2–Day 5 | 1.06±1.11 | <0.0001 | 2.55±1.37** | <0.0001 | 0.0011 |
Notes: *N=17; **N=22; Statistical significance p < 0.05.
Functional Outcomes By The Two Intervention Groups (Mean ± SD), And Comparison Between Days In Each Group (Wilcoxon Signed Rank Test; P Value) And Between Groups (Wilcoxon Scores; Rank Sum; P-Value)
| Outcome measures | Sham TENS (n=18) | p value | Active TENS (n=23) | p value | Between group |
|---|---|---|---|---|---|
| Day 1 | 2.06±0.24 | – | 2.1±0.45* | – | 1.00 |
| Day 2 | 2.17±0.38 | – | 2.35±0.57 | – | 0.3 |
| Day 3 | 2.56±0.62 | – | 2.91±0.67 | – | 0.09 |
| Day 4 | 3.06±0.54 | – | 3.61±0.58 | – | 0.003 |
| Day 5 | 3.22±0.65 | – | 3.78±0.52 | – | 0.002 |
| Day 2–Day 5 | 1.06±0.54 | <0.0001 | 1.43±0.66 | <0.0001 | 0.04 |
| 40.51±13.87 | – | 38.38±14.40 | – | 0.51 | |
| Day 5 | |||||
| 6.83±3.59 | – | 9.36±3.82 | – | 0.02 | |
| Day 5 |
Notes: *N=20; Statistical significance P < 0.05.
Abbreviations: FAC, functional ambulation classification; 5XSTS, five times sit to stand test; 2MWT, two minutes walk test.
Figure 2Numeric rating scale (NRS) values (mean ± SD) during walking on postoperative days 2 to 5.
Figure 3Functional ambulation classification (FAC) instrument values (mean ± SD) during walking postoperative days 2 to 5.